You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Reply to: Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study
  1. Henning Zeidler
  1. Correspondence to Professor Henning Zeidler, Emeritus, Medizinische Hochschule, Hannover Wolfsburger Damm 26c, Hannover 30625, Germany; henningzeidler{at}aol.com

https://doi.org/10.1136/annrheumdis-2012-202480

Statistics from Altmetric.com

    Gremese et al conclude from the real-life prospective study performed in three early arthritis clinics, that 12 weeks disease duration, and an early intervention with disease-modifying antirheumatic drugs (DMARD), represent the most significant opportunities to reach remission of rheumatoid arthritis (RA). Moreover, it is supposed that vera early RA (VERA) represents a window of opportunity in terms of cost saving.1

    A high level of confidence in the diagnosis of RA early in its course is mandatory for the validity of any study. Nevertheless, experts often disagree about diagnoses, and discrepancies may …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Correction notice This article has been corrected since it was published online first. Changes have been made to the text, and to the correspondence details.